ORGANIZATION

Drug Policy Alliance

trade association

3LINKED LD-2 FILINGS
5LINKED LOBBYISTS
0FLY-INS

Federal Lobbying Spend

$20K

Total LDA-disclosed spend (in-house + retained) across all reported periods.

Most recent LDA filing posted May 2026.

Likely Asks (from LD-2 filings)

4
opposethe Combating Xylazine Act×1

+ 3 more positions surfaced in filings — available with full intelligence access

Topics in Filings

6

In addition to the explicit asks above, these policy topics are repeatedly named in this org's LD-2 filings.

Nation wide elimination of drug felony bans for SNAP recipients/benefits×2

+ 5 more topics in the full dossier

Pulled from the org’s own LD-2 disclosures. See the source filings ↓

Limited preview · paid intelligence

Keep the intelligence current—not just this one record.

Unlock the complete ask and topic record, every bill and lobbyist connection, private team positions, engagement history, and the organization’s full recurring influence map.

Full records and recurring monitoring are paid. A work email or free alert subscription does not unlock them. Request coverage for your team; a walkthrough is optional.

Request Paid Coverage for Your TeamPrefer a walkthrough first?Already a customer? Sign inGet free intelligence alerts →

Bills in Play

10

Bills referenced in this org's LD-2 filing text. Frequency = how many activities reference each.

H.R. 5068

1 mention

H.R. 1266

1 mention

+ 8 more bills in the full intelligence view

Lobbyists on Record

5
HANNA SHARIF-KAZEMIformer Policy Manager

+ 3 more lobbyists on record — available with full intelligence access